Mankind Pharma to meet investors at Avendus Spark INDX 2025

Mankind Pharma Limited will participate in an investor conference, as per an announcement dated November 13, 2025. The company will be present at the Avendus Spark INDX 2025 - "The New Code for India's Growth" event scheduled for November 18, 2025, in Mumbai. Company officials will engage in both one-on-one and group meetings during the conference.

The intimation, released in compliance with Regulation 30 read with Part A of Schedule III of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, highlights the company's commitment to investor relations. Mankind Pharma has explicitly stated that no unpublished price-sensitive information will be shared during the conference. The company also noted that the schedule is subject to change based on mutual exigencies.

For additional details and public access, Mankind Pharma has uploaded the intimation of its participation on its official website, www.mankindpharma.com. Hitesh Kumar Jain, company secretary & compliance officer, signed the announcement for Mankind Pharma Limited.